Guilford To Receive $40 Mil. To Fund Parkinson's/ED Drug Development Via Investment Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly formed corporation of investors, Symphony Neuro Development Company, will provide the funds in exchange for five-year warrants to purchase Guilford stock and exclusive rights to the drug. Guilford has an option to reacquire the drug for $75 mil.-$120 mil. between April 2005 and March 2007.